B7H1 expression and epithelial-to-mesenchymal transition phenotypes on colorectal cancer stem-like cells

71Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

Cancer stem cells (CSCs) can invade and metastasize by epithelial-to-mesenchymal transition (EMT). However, how they escape immune surveillance is unclear. B7H1 is crucial negative co-stimulatory molecule but little information about whether it works in CSCs. Therefore, we determined the expression of B7H1 and EMT-associated markers in colorectal cancer stem-like cells to investigate a possible immunoevasion way of CSCs. We enriched CD133 + colorectal cancer cells which manifested the CSCs-like properties such as higher levels of other stem cell markers Oct-4 and Sox-2, tumor sphere forming ability and more tumorigenic in NOD/SCID mice. These CD133 + cells possess EMT gene expression profile including higher level of Snail, Twist, vimentin, fibronectin and lower level of Ecadherin. Moreover, CD133 + cells in both cell line and colorectal cancer tissues expressed high level of negative co-stimulate molecule B7H1. Furthermore, some B7H1 + cancer cells also showed the characteristic of EMT, indicating EMT cells could escape immune attack during metastasis. B7H1 expression and EMT phenotypes on CSCs indicates a possible immunoevasion way. Copyright:

Cite

CITATION STYLE

APA

Zhi, Y., Mou, Z., Chen, J., He, Y., Dong, H., Fu, X., & Wu, Y. (2015). B7H1 expression and epithelial-to-mesenchymal transition phenotypes on colorectal cancer stem-like cells. PLoS ONE, 10(8). https://doi.org/10.1371/journal.pone.0135528

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free